388 related articles for article (PubMed ID: 25116511)
1. Liposomes in topical ophthalmic drug delivery: an update.
Agarwal R; Iezhitsa I; Agarwal P; Abdul Nasir NA; Razali N; Alyautdin R; Ismail NM
Drug Deliv; 2016 May; 23(4):1075-91. PubMed ID: 25116511
[TBL] [Abstract][Full Text] [Related]
2. [Transcorneal drug delivery: prospects for the use of liposomes].
Aliautdin RN; Iezhitsa IN; Agarval R
Vestn Oftalmol; 2014; 130(4):117-22. PubMed ID: 25306734
[TBL] [Abstract][Full Text] [Related]
3. Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes.
Abdul Nasir NA; Agarwal P; Agarwal R; Iezhitsa I; Alyautdin R; Nukolova NN; Chekhonin VP; Mohd Ismail N
Drug Deliv; 2016 Oct; 23(8):2765-2771. PubMed ID: 26289215
[TBL] [Abstract][Full Text] [Related]
4. [New systems of drug administration through a topical ocular administration approach].
Herrero Vanrell R
Arch Soc Esp Oftalmol; 2001 Mar; 76(3):143-4. PubMed ID: 11283777
[No Abstract] [Full Text] [Related]
5. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D; Patra CN; Sahoo BM
Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology in ocular drug delivery.
Sahoo SK; Dilnawaz F; Krishnakumar S
Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
[TBL] [Abstract][Full Text] [Related]
7. Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection.
López-Cano JJ; González-Cela-Casamayor MA; Andrés-Guerrero V; Herrero-Vanrell R; Molina-Martínez IT
Expert Opin Drug Deliv; 2021 Jul; 18(7):819-847. PubMed ID: 33412914
[No Abstract] [Full Text] [Related]
8. Barriers to glaucoma drug delivery.
Ghate D; Edelhauser HF
J Glaucoma; 2008 Mar; 17(2):147-56. PubMed ID: 18344762
[TBL] [Abstract][Full Text] [Related]
9. Nanocarriers for ocular drug delivery: Recent advances and future opportunities.
Amrutkar CS; Patil SB
Indian J Ophthalmol; 2023 Jun; 71(6):2355-2366. PubMed ID: 37322644
[TBL] [Abstract][Full Text] [Related]
10. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
[TBL] [Abstract][Full Text] [Related]
11. Ocular delivery systems for topical application of anti-infective agents.
Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
[TBL] [Abstract][Full Text] [Related]
12. Recent patents and advances in ophthalmic drug delivery.
Janoria KG; Hariharan S; Dasari CR; Mitra AK
Recent Pat Drug Deliv Formul; 2007; 1(2):161-70. PubMed ID: 19075883
[TBL] [Abstract][Full Text] [Related]
13. Vesicular systems in ocular drug delivery: an overview.
Kaur IP; Garg A; Singla AK; Aggarwal D
Int J Pharm; 2004 Jan; 269(1):1-14. PubMed ID: 14698571
[TBL] [Abstract][Full Text] [Related]
14. Ophthalmic drug delivery systems--recent advances.
Bourlais CL; Acar L; Zia H; Sado PA; Needham T; Leverge R
Prog Retin Eye Res; 1998 Jan; 17(1):33-58. PubMed ID: 9537794
[TBL] [Abstract][Full Text] [Related]
15. Recent patents on ocular drug delivery systems.
Conway BR
Recent Pat Drug Deliv Formul; 2008; 2(1):1-8. PubMed ID: 19075892
[TBL] [Abstract][Full Text] [Related]
16. Limits on optimizing ocular drug delivery.
Keister JC; Cooper ER; Missel PJ; Lang JC; Hager DF
J Pharm Sci; 1991 Jan; 80(1):50-3. PubMed ID: 2013850
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of puerarin-dendrimer complexes as an ocular drug delivery system.
Yao W; Sun K; Mu H; Liang N; Liu Y; Yao C; Liang R; Wang A
Drug Dev Ind Pharm; 2010 Sep; 36(9):1027-35. PubMed ID: 20545508
[TBL] [Abstract][Full Text] [Related]
18. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
Jiao J
Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
[TBL] [Abstract][Full Text] [Related]
19. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive ocular drug delivery: potential transcorneal and other alternative delivery routes for therapeutic molecules in glaucoma.
Foldvari M
J Glaucoma; 2014; 23(8 Suppl 1):S80-2. PubMed ID: 25275915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
